HSD11B1

UniProt ID: P28845
Organism: Homo sapiens
Review Status: INITIALIZED
📝 Provide Detailed Feedback

Gene Description

11-beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) is an NADP(H)-dependent short-chain dehydrogenase/reductase anchored in the endoplasmic reticulum membrane as a single-pass type II membrane protein, with its catalytic domain facing the ER lumen. It catalyzes the interconversion of the inactive 11-keto glucocorticoid cortisone and the active 11-hydroxy glucocorticoid cortisol (and 11-dehydrocorticosterone/corticosterone). Although bidirectional in vitro, in vivo it acts predominantly as a reductase (cortisone to cortisol); its reductive directionality is set by the supply of NADPH generated in the ER lumen by hexose-6-phosphate dehydrogenase (H6PD). By regenerating active glucocorticoids locally, 11beta-HSD1 amplifies pre-receptor glucocorticoid action in liver, adipose tissue, brain, eye and other tissues, making it a therapeutic target in metabolic syndrome, type 2 diabetes and obesity. It functions as a homodimer and has broad substrate specificity, additionally metabolizing 7-oxo/7-hydroxy oxysterols (e.g. 7-ketocholesterol), 7-oxo bile acids, neurosteroids and 11-oxygenated C19 steroids. Loss or reduction of activity causes cortisone reductase deficiency.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0006706 steroid catabolic process
IBA
GO_REF:0000033
MODIFY
Summary: Phylogenetically-inferred biological process. HSD11B1 does participate in steroid metabolism, but its predominant physiological role is reductive activation of glucocorticoids (cortisone to cortisol), i.e. metabolism/interconversion rather than catabolism. The catabolic framing fits some oxidative or oxysterol reactions but is imprecise for the core function.
Reason: Steroid catabolic process mischaracterizes the core in-vivo activity, which is reductive regeneration of active cortisol (a glucocorticoid metabolic/interconversion process), not steroid breakdown. Generalize/re-target to glucocorticoid metabolic process, which correctly covers the bidirectional interconversion of active and inactive glucocorticoids.
Propagation Review
Root cause: TERM SCOPING PROBLEM
Failure modes: GRANULARITY MISMATCH
Proposed replacements: glucocorticoid metabolic process
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
functions as a reductase in vivo, thereby increasing the concentration
file:human/HSD11B1/HSD11B1-uniprot.txt
of active glucocorticoids
GO:0005789 endoplasmic reticulum membrane
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically-inferred localization to the ER membrane, consistent with direct experimental evidence that 11beta-HSD1 is an ER-membrane protein with its catalytic domain in the ER lumen. This is the core cellular location where the enzyme acts.
Reason: Well supported by experimental localization data; the enzyme is active in the ER membrane (lumen-facing catalytic domain).
Supporting Evidence:
PMID:10497248
localization of both 11beta-HSD1 and
PMID:10497248
the catalytic domain containing the C terminus is protruding into the ER
GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically-inferred core molecular function. This is the defining catalytic activity of HSD11B1, corroborated by numerous experimental (IDA) annotations and the UniProt catalytic-activity record (EC 1.1.1.146; 11beta-hydroxysteroid + NADP(+) = 11-oxosteroid + NADPH). This is the core molecular function.
Reason: Definitive, well-supported core enzymatic activity of the gene product.
Supporting Evidence:
PMID:15513927
ER-localized membrane protein that catalyzes the interconversion of cortisone
file:human/HSD11B1/HSD11B1-uniprot.txt
Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
GO:0005496 steroid binding
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: Phylogenetically-inferred steroid binding, reflecting the enzyme's binding of steroid substrates (glucocorticoids and other steroid/sterol substrates) in its active site. This is a real but generic molecular function that is subsidiary to the catalytic activity.
Reason: Substrate binding is genuine but is an aspect of the catalytic mechanism rather than an independent core function; the informative core MF is the dehydrogenase activity.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
besides glucocorticoids, it accepts other steroid and sterol substrates
GO:0004090 carbonyl reductase (NADPH) activity
IEA
GO_REF:0000116
MARK AS OVER ANNOTATED
Summary: RHEA-based electronic annotation. HSD11B1 does perform NADPH-dependent carbonyl (oxo) reductions on several substrates (e.g. 7-oxo bile acids, oxysterols), so the term is not wrong, but it is a broad generic parent that is far less informative than the specific 11-beta-hydroxysteroid dehydrogenase and cortisol dehydrogenase activities.
Reason: Correct in essence (NADPH-dependent carbonyl reduction occurs) but overly general; the specific dehydrogenase activities better describe the function.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
GO:0005789 endoplasmic reticulum membrane
IEA
GO_REF:0000044
ACCEPT
Summary: Electronic annotation from the UniProt Subcellular Location vocabulary mapping, consistent with experimental evidence that 11beta-HSD1 is an ER-membrane protein.
Reason: Correct core localization, agreeing with experimental (IDA) and phylogenetic (IBA) evidence.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
Endoplasmic reticulum membrane
file:human/HSD11B1/HSD11B1-uniprot.txt
type II membrane protein
GO:0047022 7-beta-hydroxysteroid dehydrogenase (NADP+) activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic annotation (EC 1.1.1.201). HSD11B1 has documented 7-oxosteroid reductase / 7beta-hydroxysteroid dehydrogenase activity, interconverting 7-oxo and 7beta-hydroxy sterols/bile acids/neurosteroids (e.g. 7-ketocholesterol to 7beta-hydroxycholesterol). This is a real secondary catalytic activity of the enzyme.
Reason: EC-backed secondary activity supported by the UniProt catalytic-activity record and by experimental oxysterol/bile-acid studies; a genuine additional molecular function.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
a 7beta-hydroxysteroid + NADP(+) = a 7-oxosteroid + NADPH +
PMID:15152005
potential role in 7-ketocholesterol metabolism.
GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic annotation (EC 1.1.1.146) for the core 11beta-HSD activity. Duplicates the IBA and IDA annotations of the same term and is fully supported.
Reason: Correct core molecular function; duplicate of the experimentally and phylogenetically supported term.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
GO:0102196 cortisol dehydrogenase (NADP+) activity
IEA
GO_REF:0000116
ACCEPT
Summary: RHEA-based electronic annotation (RHEA:68616, cortisone + NADPH = cortisol + NADP(+)) capturing the physiologically dominant reductive reaction of HSD11B1, the regeneration of active cortisol from cortisone. This is a specific and accurate representation of the core in-vivo function.
Reason: Specific, biologically accurate term for the enzyme's predominant in-vivo reductase reaction (cortisone to cortisol); complements the broader 11beta-HSD activity term.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
PMID:15513927
ER-localized membrane protein that catalyzes the interconversion of cortisone
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-194023
ACCEPT
Summary: Reactome-asserted ER-membrane localization for the HSD11B1-containing reaction. Consistent with all other localization evidence for this enzyme.
Reason: Correct core localization, supported by experimental and phylogenetic evidence.
Supporting Evidence:
PMID:10497248
localization of both 11beta-HSD1 and
GO:0005789 endoplasmic reticulum membrane
TAS
Reactome:R-HSA-9757706
ACCEPT
Summary: Reactome-asserted ER-membrane localization for a hepatic HSD11B1 reaction (prednisone to prednisolone reduction). Consistent with all other localization evidence.
Reason: Correct core localization, supported by experimental and phylogenetic evidence.
Supporting Evidence:
PMID:10497248
the catalytic domain containing the C terminus is protruding into the ER
GO:0005789 endoplasmic reticulum membrane
IDA
PMID:10497248
The N-terminal anchor sequences of 11beta-hydroxysteroid deh...
ACCEPT
Summary: Direct experimental evidence (fluorescence microscopy and protease-protection assays) localizing 11beta-HSD1 to the ER membrane, with the catalytic C-terminal domain protruding into the ER lumen and the N-terminus cytoplasmic (single-pass type II membrane topology). This anchors the core localization.
Reason: High-quality direct experimental evidence for the core ER-membrane localization.
Supporting Evidence:
PMID:10497248
the N terminus of 11beta-HSD1 is cytoplasmic,
PMID:10497248
the catalytic domain containing the C terminus is protruding into the ER
GO:0042803 protein homodimerization activity
IDA
PMID:15513927
Conformational flexibility in crystal structures of human 11...
ACCEPT
Summary: Crystallographic evidence that human 11beta-HSD1 assembles as a homo-oligomer; the structures show the C-termini of subunits converging to form an oligomerization motif. UniProt records the enzyme as a homodimer. The homodimerization is genuine but is a structural/quaternary property rather than the informative core molecular function.
Reason: Homodimerization is directly demonstrated by crystal structures and recorded by UniProt; a real molecular property, kept but not the core catalytic function.
Supporting Evidence:
PMID:15513927
four 11beta-HSD1 C termini converge to form an as yet
file:human/HSD11B1/HSD11B1-uniprot.txt
SUBUNIT: Homodimer.
GO:0042803 protein homodimerization activity
IDA
PMID:17919905
The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibit...
ACCEPT
Summary: X-ray co-crystal structure of 11beta-HSD1 (in complex with NADP and an inhibitor) supporting the oligomeric assembly of the enzyme. Consistent with the UniProt homodimer annotation.
Reason: Structural evidence supports homodimerization; genuine quaternary structure, retained as a non-core property.
Supporting Evidence:
PMID:17919905
The binding mode was determined through the X-ray co-crystal
file:human/HSD11B1/HSD11B1-uniprot.txt
SUBUNIT: Homodimer.
GO:0042803 protein homodimerization activity
IDA
PMID:18069989
Structural characterization and pharmacodynamic effects of a...
ACCEPT
Summary: X-ray crystallographic characterization of an orally active 11beta-HSD1 inhibitor complex, contributing structural support for the homodimeric assembly of the enzyme, as recorded by UniProt.
Reason: Structural evidence supports homodimerization; retained as a real non-core property.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
SUBUNIT: Homodimer.
GO:0042803 protein homodimerization activity
IDA
PMID:18485702
Pyridine amides as potent and selective inhibitors of 11beta...
ACCEPT
Summary: X-ray crystal structure of 11beta-HSD1 in complex with NADP and an inhibitor, contributing structural evidence consistent with the homodimeric assembly recorded by UniProt.
Reason: Structural evidence supports homodimerization; retained as a real non-core property.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
SUBUNIT: Homodimer.
GO:0042803 protein homodimerization activity
IDA
PMID:18553955
Discovery of novel, potent benzamide inhibitors of 11beta-hy...
ACCEPT
Summary: Crystallographic study of benzamide inhibitor complexes of 11beta-HSD1, contributing structural support for the enzyme's homodimeric assembly recorded by UniProt.
Reason: Structural evidence supports homodimerization; retained as a real non-core property.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
SUBUNIT: Homodimer.
GO:0042803 protein homodimerization activity
IDA
PMID:19217779
Discovery and optimization of piperidyl benzamide derivative...
ACCEPT
Summary: Crystallographic study of piperidyl benzamide inhibitor complexes of 11beta-HSD1, contributing structural support for the enzyme's homodimeric assembly recorded by UniProt.
Reason: Structural evidence supports homodimerization; retained as a real non-core property.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
SUBUNIT: Homodimer.
GO:0050661 NADP binding
IDA
PMID:15513927
Conformational flexibility in crystal structures of human 11...
KEEP AS NON CORE
Summary: NADP(H) is the obligate cofactor of 11beta-HSD1, and crystal structures were solved as ternary complexes containing NADP. NADP binding is a genuine molecular function but is a cofactor-binding aspect of the catalytic mechanism rather than the informative core MF.
Reason: Cofactor binding is real and structurally demonstrated but subsidiary to the dehydrogenase activity, which is the core function.
Supporting Evidence:
PMID:15513927
two ternary complexes of 11beta-HSD1
file:human/HSD11B1/HSD11B1-uniprot.txt
cosubstrate NADPH
GO:0050661 NADP binding
IDA
PMID:17919905
The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibit...
KEEP AS NON CORE
Summary: X-ray co-crystal structure with NADP demonstrating cofactor binding. Genuine but subsidiary to the core dehydrogenase activity.
Reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
Supporting Evidence:
PMID:17919905
The binding mode was determined through the X-ray co-crystal
GO:0050661 NADP binding
IDA
PMID:18069989
Structural characterization and pharmacodynamic effects of a...
KEEP AS NON CORE
Summary: Structural characterization of an 11beta-HSD1 complex demonstrating NADP cofactor binding. Genuine but subsidiary to the core dehydrogenase activity.
Reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
cosubstrate NADPH
GO:0050661 NADP binding
IDA
PMID:18485702
Pyridine amides as potent and selective inhibitors of 11beta...
KEEP AS NON CORE
Summary: Crystal structure of 11beta-HSD1 in complex with NADP demonstrating cofactor binding. Genuine but subsidiary to the core dehydrogenase activity.
Reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
cosubstrate NADPH
GO:0050661 NADP binding
IDA
PMID:18553955
Discovery of novel, potent benzamide inhibitors of 11beta-hy...
KEEP AS NON CORE
Summary: Crystallographic evidence of NADP cofactor binding by 11beta-HSD1. Genuine but subsidiary to the core dehydrogenase activity.
Reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
cosubstrate NADPH
GO:0050661 NADP binding
IDA
PMID:19217779
Discovery and optimization of piperidyl benzamide derivative...
KEEP AS NON CORE
Summary: Crystallographic evidence of NADP cofactor binding by 11beta-HSD1. Genuine but subsidiary to the core dehydrogenase activity.
Reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
Supporting Evidence:
file:human/HSD11B1/HSD11B1-uniprot.txt
cosubstrate NADPH
GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
IDA
PMID:10497248
The N-terminal anchor sequences of 11beta-hydroxysteroid deh...
ACCEPT
Summary: Direct experimental measurement of 11beta-HSD1 enzymatic activity (glucocorticoid interconversion with defined kinetics for corticosterone and 11-dehydrocorticosterone) in the study that also established ER-membrane topology. Supports the core catalytic function.
Reason: Direct experimental evidence for the core 11beta-HSD (NADP+) activity.
Supporting Evidence:
PMID:10497248
regulate the ratio of
PMID:10497248
active endogenous glucocorticoids to their inactive keto-metabolites
GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
IDA
PMID:15152005
Appropriate function of 11beta-hydroxysteroid dehydrogenase ...
ACCEPT
Summary: Direct experimental evidence that the ER-lumen-oriented 11beta-HSD1 carries out efficient glucocorticoid oxidoreduction (cortisol oxidation shown to depend on luminal orientation), establishing the core catalytic activity and its pre-receptor role.
Reason: Direct experimental evidence for the core 11beta-HSD (NADP+) activity.
Supporting Evidence:
PMID:15152005
11beta-HSD1) exerts an important pre-receptor function
PMID:15152005
essential for efficient oxidation of cortisol.
GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
IDA
PMID:17070044
Adamantane sulfone and sulfonamide 11-beta-HSD1 Inhibitors.
ACCEPT
Summary: Enzyme-inhibition study demonstrating 11beta-HSD1 catalytic activity in liver, fat and brain (target of adamantane sulfone/sulfonamide inhibitors), consistent with the core dehydrogenase activity of the enzyme.
Reason: Experimental evidence of the core enzymatic activity via inhibitor-based assays.
Supporting Evidence:
PMID:17070044
strongly inhibit liver, fat, and brain HSD1
GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
IDA
PMID:17919905
The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibit...
ACCEPT
Summary: Enzyme-inhibition and X-ray co-crystal study confirming the 11beta-HSD1 catalytic activity used as the assay target, consistent with the core dehydrogenase function.
Reason: Experimental evidence of the core enzymatic activity in an inhibitor/structure study.
Supporting Evidence:
PMID:17919905
2-anilinothiazolones were prepared as inhibitors of
GO:0016020 membrane
HDA
PMID:19946888
Defining the membrane proteome of NK cells.
MARK AS OVER ANNOTATED
Summary: High-throughput mass-spectrometry membrane-proteome study of an NK-like cell line that identified HSD11B1 among ~1843 proteins. "Membrane" is a generic parent of the specific and well-supported ER-membrane localization, and the annotation derives from a broad proteomics screen rather than targeted localization.
Reason: Not wrong (the enzyme is a membrane protein) but uninformatively general relative to the specific ER membrane localization; sourced from a high-throughput proteomics dataset.
Supporting Evidence:
PMID:19946888
identified 1843 proteins with high confidence scores

Core Functions

NADP(H)-dependent 11-beta-hydroxysteroid dehydrogenase / oxoreductase that interconverts inactive and active glucocorticoids, acting predominantly in vivo as a reductase converting cortisone to cortisol at the ER membrane, thereby amplifying pre-receptor glucocorticoid action.

Supporting Evidence:
  • file:human/HSD11B1/HSD11B1-uniprot.txt
    Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
  • PMID:15513927
    ER-localized membrane protein that catalyzes the interconversion of cortisone

References

Annotation inferences using phylogenetic trees
Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
Automatic Gene Ontology annotation based on Rhea mapping
Combined Automated Annotation using Multiple IEA Methods
file:human/HSD11B1/HSD11B1-uniprot.txt
UniProtKB entry P28845 (DHI1_HUMAN), 11-beta-hydroxysteroid dehydrogenase 1
The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine their orientation in the endoplasmic reticulum membrane.
Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar topological determinants with 50-kDa esterase.
Conformational flexibility in crystal structures of human 11beta-hydroxysteroid dehydrogenase type I provide insights into glucocorticoid interconversion and enzyme regulation.
Adamantane sulfone and sulfonamide 11-beta-HSD1 Inhibitors.
The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitors.
Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor.
Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model.
Discovery and optimization of piperidyl benzamide derivatives as a novel class of 11beta-HSD1 inhibitors.
Defining the membrane proteome of NK cells.
Reactome:R-HSA-194023
HSD11B2,HSD11B1 dimer oxidise CORT to COR
Reactome:R-HSA-9757706
HSD11B1 hydrogenates PREDN to PREDL in hepatic cell

📚 Additional Documentation

Notes

(HSD11B1-notes.md)

HSD11B1 (P28845) review notes

Identity

  • 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1), a.k.a. cortisone reductase,
    corticosteroid 11-beta-dehydrogenase isozyme 1, SDR26C1, 7-oxosteroid reductase.
  • 292 aa, short-chain dehydrogenase/reductase (SDR) family member.
  • EC 1.1.1.146 (11beta-HSD) and EC 1.1.1.201 (7-oxosteroid / 7beta-HSD).

Core biology (from UniProt P28845 + abstracts)

  • NADP(H)-dependent enzyme; single-pass type II membrane protein of the ER membrane, with
    the catalytic C-terminal domain protruding into the ER lumen PMID:10497248.
  • Interconverts inactive cortisone <-> active cortisol (and 11-dehydrocorticosterone <->
    corticosterone). Bidirectional in vitro, but predominantly a REDUCTASE in vivo (cortisone
    -> cortisol), amplifying local glucocorticoid concentrations = "pre-receptor" glucocorticoid
    activation [UniProt FUNCTION; PMID:15152005 "pre-receptor function"].
  • Directionality is set by NADPH supply: ER-lumenal hexose-6-phosphate dehydrogenase (H6PD)
    regenerates NADPH and drives HSD11B1 as an oxoreductase; the G6P transporter supplies H6PD
    substrate [UniProt ACTIVITY REGULATION; PMID:15280030 (Atanasov 2004), PMID:17593962].
  • Broad substrate range beyond glucocorticoids: 7-oxo/7beta-hydroxy oxysterols
    (7-ketocholesterol -> 7beta-hydroxycholesterol), 7-oxo bile acids (7-oxolithocholate ->
    chenodeoxycholate/ursodeoxycholate), 7-oxo/7beta-hydroxy neurosteroids, 11-oxy C19 steroids.
  • Highest expression in liver; also adipose, brain, eye (cornea/ciliary epithelium), gonad.
    Drug target for metabolic syndrome / type 2 diabetes / obesity because adipose 11beta-HSD1
    cortisol regeneration drives visceral adiposity PMID:15513927.
  • Homodimer (crystal structures show tetramerization motif at C-termini)
    [PMID:15513927, PMID:17919905, PMID:18069989, PMID:18485702, PMID:18553955, PMID:19217779].
  • Disease: cortisone reductase deficiency 2 (CORTRD2, MIM:614662) — failure to regenerate
    cortisol from cortisone, ACTH-driven adrenal androgen excess PMID:12858176.

Curation reasoning for GOA lines

  • MF 11beta-HSD (NADP+) activity GO:0070524 = CORE (IBA + multiple IDA). ACCEPT.
  • MF cortisol dehydrogenase (NADP+) GO:0102196 (RHEA IEA, RHEA:68616 cortisone+NADPH=cortisol+NADP)
    captures the physiologically dominant reductase reaction; ACCEPT (more specific than parent).
  • MF carbonyl reductase (NADPH) GO:0004090 (RHEA IEA) is a broad generic parent capturing the
    bile-acid/oxysterol 7-oxo reductions; not the informative core term but not wrong -> MARK_AS_OVER_ANNOTATED.
  • MF 7beta-HSD (NADP+) GO:0047022 (EC 1.1.1.201 IEA) supported by oxysterol/bile-acid data
    (PMID:15095019, 14973125, 21453287). ACCEPT (secondary but real, EC-backed moonlighting activity).
  • MF steroid binding GO:0005496 (IBA) — substrate binding, real but generic; KEEP_AS_NON_CORE.
  • MF NADP binding GO:0050661 (6x IDA, all from crystal-structure/inhibitor papers with NADP in
    complex) — cofactor binding, real; KEEP_AS_NON_CORE (cofactor, not the informative core MF).
  • MF protein homodimerization GO:0042803 (6x IDA) — homodimer confirmed by crystallography;
    ACCEPT (real quaternary structure), keep as non-core relative to catalysis.
  • CC ER membrane GO:0005789 (IBA is_active_in, IEA SubCell, 2x Reactome TAS, IDA PMID:10497248)
    = CORE localization. ACCEPT.
  • CC membrane GO:0016020 (HDA, NK-cell membrane proteome MS PMID:19946888) — generic parent of
    ER membrane, HTP proteomics; MARK_AS_OVER_ANNOTATED.
  • BP steroid catabolic process GO:0006706 (IBA) — HSD11B1's core in-vivo action is reductive
    ACTIVATION not catabolism; the oxidative/oxysterol directions can be catabolic but the term
    is imprecise for the core role -> MODIFY to glucocorticoid metabolic process GO:0008211.

core_functions choices

  • MF: GO:0070524 11-beta-hydroxysteroid dehydrogenase (NADP+) activity.
  • BP (directly_involved_in): GO:0008211 glucocorticoid metabolic process.
    (Note: GO:0034651 cortisol biosynthetic process is defined as de novo synthesis from
    cholesterol in the adrenal gland — HSD11B1 does pre-receptor regeneration, not de novo
    synthesis, so glucocorticoid metabolic process is the accurate BP.)
  • CC (located_in): GO:0005789 endoplasmic reticulum membrane.

Sources

  • publications/PMID_*.md are all abstract-only (full_text_available: false).
  • Deep research not available (falcon out of credits, HTTP 402). Grounded in UniProt + abstracts + GOA.

📄 View Raw YAML

id: P28845
gene_symbol: HSD11B1
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: 11-beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) is an NADP(H)-dependent
  short-chain dehydrogenase/reductase anchored in the endoplasmic reticulum membrane as a
  single-pass type II membrane protein, with its catalytic domain facing the ER lumen. It
  catalyzes the interconversion of the inactive 11-keto glucocorticoid cortisone and the
  active 11-hydroxy glucocorticoid cortisol (and 11-dehydrocorticosterone/corticosterone).
  Although bidirectional in vitro, in vivo it acts predominantly as a reductase (cortisone
  to cortisol); its reductive directionality is set by the supply of NADPH generated in the
  ER lumen by hexose-6-phosphate dehydrogenase (H6PD). By regenerating active glucocorticoids
  locally, 11beta-HSD1 amplifies pre-receptor glucocorticoid action in liver, adipose tissue,
  brain, eye and other tissues, making it a therapeutic target in metabolic syndrome, type 2
  diabetes and obesity. It functions as a homodimer and has broad substrate specificity,
  additionally metabolizing 7-oxo/7-hydroxy oxysterols (e.g. 7-ketocholesterol), 7-oxo bile
  acids, neurosteroids and 11-oxygenated C19 steroids. Loss or reduction of activity causes
  cortisone reductase deficiency.
existing_annotations:
- term:
    id: GO:0006706
    label: steroid catabolic process
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: Phylogenetically-inferred biological process. HSD11B1 does participate in steroid
      metabolism, but its predominant physiological role is reductive activation of
      glucocorticoids (cortisone to cortisol), i.e. metabolism/interconversion rather than
      catabolism. The catabolic framing fits some oxidative or oxysterol reactions but is
      imprecise for the core function.
    action: MODIFY
    reason: Steroid catabolic process mischaracterizes the core in-vivo activity, which is
      reductive regeneration of active cortisol (a glucocorticoid metabolic/interconversion
      process), not steroid breakdown. Generalize/re-target to glucocorticoid metabolic process,
      which correctly covers the bidirectional interconversion of active and inactive
      glucocorticoids.
    proposed_replacement_terms:
    - id: GO:0008211
      label: glucocorticoid metabolic process
    propagation_review:
      root_cause: TERM_SCOPING_PROBLEM
      failure_modes:
      - GRANULARITY_MISMATCH
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: functions as a reductase in vivo, thereby increasing the concentration
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: of active glucocorticoids
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: Phylogenetically-inferred localization to the ER membrane, consistent with direct
      experimental evidence that 11beta-HSD1 is an ER-membrane protein with its catalytic
      domain in the ER lumen. This is the core cellular location where the enzyme acts.
    action: ACCEPT
    reason: Well supported by experimental localization data; the enzyme is active in the ER
      membrane (lumen-facing catalytic domain).
    supported_by:
    - reference_id: PMID:10497248
      supporting_text: localization of both 11beta-HSD1 and
    - reference_id: PMID:10497248
      supporting_text: the catalytic domain containing the C terminus is protruding into the ER
- term:
    id: GO:0070524
    label: 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: Phylogenetically-inferred core molecular function. This is the defining catalytic
      activity of HSD11B1, corroborated by numerous experimental (IDA) annotations and the
      UniProt catalytic-activity record (EC 1.1.1.146; 11beta-hydroxysteroid + NADP(+) =
      11-oxosteroid + NADPH). This is the core molecular function.
    action: ACCEPT
    reason: Definitive, well-supported core enzymatic activity of the gene product.
    supported_by:
    - reference_id: PMID:15513927
      supporting_text: ER-localized membrane protein that catalyzes the interconversion of cortisone
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
- term:
    id: GO:0005496
    label: steroid binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: Phylogenetically-inferred steroid binding, reflecting the enzyme's binding of
      steroid substrates (glucocorticoids and other steroid/sterol substrates) in its active
      site. This is a real but generic molecular function that is subsidiary to the catalytic
      activity.
    action: KEEP_AS_NON_CORE
    reason: Substrate binding is genuine but is an aspect of the catalytic mechanism rather than
      an independent core function; the informative core MF is the dehydrogenase activity.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: besides glucocorticoids, it accepts other steroid and sterol substrates
- term:
    id: GO:0004090
    label: carbonyl reductase (NADPH) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: RHEA-based electronic annotation. HSD11B1 does perform NADPH-dependent carbonyl
      (oxo) reductions on several substrates (e.g. 7-oxo bile acids, oxysterols), so the term
      is not wrong, but it is a broad generic parent that is far less informative than the
      specific 11-beta-hydroxysteroid dehydrogenase and cortisol dehydrogenase activities.
    action: MARK_AS_OVER_ANNOTATED
    reason: Correct in essence (NADPH-dependent carbonyl reduction occurs) but overly general;
      the specific dehydrogenase activities better describe the function.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  qualifier: located_in
  review:
    summary: Electronic annotation from the UniProt Subcellular Location vocabulary mapping,
      consistent with experimental evidence that 11beta-HSD1 is an ER-membrane protein.
    action: ACCEPT
    reason: Correct core localization, agreeing with experimental (IDA) and phylogenetic (IBA)
      evidence.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: Endoplasmic reticulum membrane
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: type II membrane protein
- term:
    id: GO:0047022
    label: 7-beta-hydroxysteroid dehydrogenase (NADP+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: Electronic annotation (EC 1.1.1.201). HSD11B1 has documented 7-oxosteroid
      reductase / 7beta-hydroxysteroid dehydrogenase activity, interconverting 7-oxo and
      7beta-hydroxy sterols/bile acids/neurosteroids (e.g. 7-ketocholesterol to
      7beta-hydroxycholesterol). This is a real secondary catalytic activity of the enzyme.
    action: ACCEPT
    reason: EC-backed secondary activity supported by the UniProt catalytic-activity record and
      by experimental oxysterol/bile-acid studies; a genuine additional molecular function.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: a 7beta-hydroxysteroid + NADP(+) = a 7-oxosteroid + NADPH +
    - reference_id: PMID:15152005
      supporting_text: potential role in 7-ketocholesterol metabolism.
- term:
    id: GO:0070524
    label: 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: Electronic annotation (EC 1.1.1.146) for the core 11beta-HSD activity. Duplicates
      the IBA and IDA annotations of the same term and is fully supported.
    action: ACCEPT
    reason: Correct core molecular function; duplicate of the experimentally and phylogenetically
      supported term.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
- term:
    id: GO:0102196
    label: cortisol dehydrogenase (NADP+) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000116
  qualifier: enables
  review:
    summary: RHEA-based electronic annotation (RHEA:68616, cortisone + NADPH = cortisol +
      NADP(+)) capturing the physiologically dominant reductive reaction of HSD11B1, the
      regeneration of active cortisol from cortisone. This is a specific and accurate
      representation of the core in-vivo function.
    action: ACCEPT
    reason: Specific, biologically accurate term for the enzyme's predominant in-vivo reductase
      reaction (cortisone to cortisol); complements the broader 11beta-HSD activity term.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
    - reference_id: PMID:15513927
      supporting_text: ER-localized membrane protein that catalyzes the interconversion of cortisone
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-194023
  qualifier: located_in
  review:
    summary: Reactome-asserted ER-membrane localization for the HSD11B1-containing reaction.
      Consistent with all other localization evidence for this enzyme.
    action: ACCEPT
    reason: Correct core localization, supported by experimental and phylogenetic evidence.
    supported_by:
    - reference_id: PMID:10497248
      supporting_text: localization of both 11beta-HSD1 and
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9757706
  qualifier: located_in
  review:
    summary: Reactome-asserted ER-membrane localization for a hepatic HSD11B1 reaction
      (prednisone to prednisolone reduction). Consistent with all other localization evidence.
    action: ACCEPT
    reason: Correct core localization, supported by experimental and phylogenetic evidence.
    supported_by:
    - reference_id: PMID:10497248
      supporting_text: the catalytic domain containing the C terminus is protruding into the ER
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IDA
  original_reference_id: PMID:10497248
  qualifier: located_in
  review:
    summary: Direct experimental evidence (fluorescence microscopy and protease-protection
      assays) localizing 11beta-HSD1 to the ER membrane, with the catalytic C-terminal domain
      protruding into the ER lumen and the N-terminus cytoplasmic (single-pass type II membrane
      topology). This anchors the core localization.
    action: ACCEPT
    reason: High-quality direct experimental evidence for the core ER-membrane localization.
    supported_by:
    - reference_id: PMID:10497248
      supporting_text: the N terminus of 11beta-HSD1 is cytoplasmic,
    - reference_id: PMID:10497248
      supporting_text: the catalytic domain containing the C terminus is protruding into the ER
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: IDA
  original_reference_id: PMID:15513927
  qualifier: enables
  review:
    summary: Crystallographic evidence that human 11beta-HSD1 assembles as a homo-oligomer;
      the structures show the C-termini of subunits converging to form an oligomerization motif.
      UniProt records the enzyme as a homodimer. The homodimerization is genuine but is a
      structural/quaternary property rather than the informative core molecular function.
    action: ACCEPT
    reason: Homodimerization is directly demonstrated by crystal structures and recorded by
      UniProt; a real molecular property, kept but not the core catalytic function.
    supported_by:
    - reference_id: PMID:15513927
      supporting_text: four 11beta-HSD1 C termini converge to form an as yet
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: "SUBUNIT: Homodimer."
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: IDA
  original_reference_id: PMID:17919905
  qualifier: enables
  review:
    summary: X-ray co-crystal structure of 11beta-HSD1 (in complex with NADP and an inhibitor)
      supporting the oligomeric assembly of the enzyme. Consistent with the UniProt homodimer
      annotation.
    action: ACCEPT
    reason: Structural evidence supports homodimerization; genuine quaternary structure, retained
      as a non-core property.
    supported_by:
    - reference_id: PMID:17919905
      supporting_text: The binding mode was determined through the X-ray co-crystal
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: "SUBUNIT: Homodimer."
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: IDA
  original_reference_id: PMID:18069989
  qualifier: enables
  review:
    summary: X-ray crystallographic characterization of an orally active 11beta-HSD1 inhibitor
      complex, contributing structural support for the homodimeric assembly of the enzyme, as
      recorded by UniProt.
    action: ACCEPT
    reason: Structural evidence supports homodimerization; retained as a real non-core property.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: "SUBUNIT: Homodimer."
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: IDA
  original_reference_id: PMID:18485702
  qualifier: enables
  review:
    summary: X-ray crystal structure of 11beta-HSD1 in complex with NADP and an inhibitor,
      contributing structural evidence consistent with the homodimeric assembly recorded by
      UniProt.
    action: ACCEPT
    reason: Structural evidence supports homodimerization; retained as a real non-core property.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: "SUBUNIT: Homodimer."
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: IDA
  original_reference_id: PMID:18553955
  qualifier: enables
  review:
    summary: Crystallographic study of benzamide inhibitor complexes of 11beta-HSD1,
      contributing structural support for the enzyme's homodimeric assembly recorded by UniProt.
    action: ACCEPT
    reason: Structural evidence supports homodimerization; retained as a real non-core property.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: "SUBUNIT: Homodimer."
- term:
    id: GO:0042803
    label: protein homodimerization activity
  evidence_type: IDA
  original_reference_id: PMID:19217779
  qualifier: enables
  review:
    summary: Crystallographic study of piperidyl benzamide inhibitor complexes of 11beta-HSD1,
      contributing structural support for the enzyme's homodimeric assembly recorded by UniProt.
    action: ACCEPT
    reason: Structural evidence supports homodimerization; retained as a real non-core property.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: "SUBUNIT: Homodimer."
- term:
    id: GO:0050661
    label: NADP binding
  evidence_type: IDA
  original_reference_id: PMID:15513927
  qualifier: enables
  review:
    summary: NADP(H) is the obligate cofactor of 11beta-HSD1, and crystal structures were solved
      as ternary complexes containing NADP. NADP binding is a genuine molecular function but is
      a cofactor-binding aspect of the catalytic mechanism rather than the informative core MF.
    action: KEEP_AS_NON_CORE
    reason: Cofactor binding is real and structurally demonstrated but subsidiary to the
      dehydrogenase activity, which is the core function.
    supported_by:
    - reference_id: PMID:15513927
      supporting_text: two ternary complexes of 11beta-HSD1
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: cosubstrate NADPH
- term:
    id: GO:0050661
    label: NADP binding
  evidence_type: IDA
  original_reference_id: PMID:17919905
  qualifier: enables
  review:
    summary: X-ray co-crystal structure with NADP demonstrating cofactor binding. Genuine but
      subsidiary to the core dehydrogenase activity.
    action: KEEP_AS_NON_CORE
    reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
    supported_by:
    - reference_id: PMID:17919905
      supporting_text: The binding mode was determined through the X-ray co-crystal
- term:
    id: GO:0050661
    label: NADP binding
  evidence_type: IDA
  original_reference_id: PMID:18069989
  qualifier: enables
  review:
    summary: Structural characterization of an 11beta-HSD1 complex demonstrating NADP cofactor
      binding. Genuine but subsidiary to the core dehydrogenase activity.
    action: KEEP_AS_NON_CORE
    reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: cosubstrate NADPH
- term:
    id: GO:0050661
    label: NADP binding
  evidence_type: IDA
  original_reference_id: PMID:18485702
  qualifier: enables
  review:
    summary: Crystal structure of 11beta-HSD1 in complex with NADP demonstrating cofactor
      binding. Genuine but subsidiary to the core dehydrogenase activity.
    action: KEEP_AS_NON_CORE
    reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: cosubstrate NADPH
- term:
    id: GO:0050661
    label: NADP binding
  evidence_type: IDA
  original_reference_id: PMID:18553955
  qualifier: enables
  review:
    summary: Crystallographic evidence of NADP cofactor binding by 11beta-HSD1. Genuine but
      subsidiary to the core dehydrogenase activity.
    action: KEEP_AS_NON_CORE
    reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: cosubstrate NADPH
- term:
    id: GO:0050661
    label: NADP binding
  evidence_type: IDA
  original_reference_id: PMID:19217779
  qualifier: enables
  review:
    summary: Crystallographic evidence of NADP cofactor binding by 11beta-HSD1. Genuine but
      subsidiary to the core dehydrogenase activity.
    action: KEEP_AS_NON_CORE
    reason: Structurally demonstrated cofactor binding, retained as a non-core molecular function.
    supported_by:
    - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
      supporting_text: cosubstrate NADPH
- term:
    id: GO:0070524
    label: 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
  evidence_type: IDA
  original_reference_id: PMID:10497248
  qualifier: enables
  review:
    summary: Direct experimental measurement of 11beta-HSD1 enzymatic activity (glucocorticoid
      interconversion with defined kinetics for corticosterone and 11-dehydrocorticosterone) in
      the study that also established ER-membrane topology. Supports the core catalytic function.
    action: ACCEPT
    reason: Direct experimental evidence for the core 11beta-HSD (NADP+) activity.
    supported_by:
    - reference_id: PMID:10497248
      supporting_text: regulate the ratio of
    - reference_id: PMID:10497248
      supporting_text: active endogenous glucocorticoids to their inactive keto-metabolites
- term:
    id: GO:0070524
    label: 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
  evidence_type: IDA
  original_reference_id: PMID:15152005
  qualifier: enables
  review:
    summary: Direct experimental evidence that the ER-lumen-oriented 11beta-HSD1 carries out
      efficient glucocorticoid oxidoreduction (cortisol oxidation shown to depend on luminal
      orientation), establishing the core catalytic activity and its pre-receptor role.
    action: ACCEPT
    reason: Direct experimental evidence for the core 11beta-HSD (NADP+) activity.
    supported_by:
    - reference_id: PMID:15152005
      supporting_text: 11beta-HSD1) exerts an important pre-receptor function
    - reference_id: PMID:15152005
      supporting_text: essential for efficient oxidation of cortisol.
- term:
    id: GO:0070524
    label: 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
  evidence_type: IDA
  original_reference_id: PMID:17070044
  qualifier: enables
  review:
    summary: Enzyme-inhibition study demonstrating 11beta-HSD1 catalytic activity in liver, fat
      and brain (target of adamantane sulfone/sulfonamide inhibitors), consistent with the core
      dehydrogenase activity of the enzyme.
    action: ACCEPT
    reason: Experimental evidence of the core enzymatic activity via inhibitor-based assays.
    supported_by:
    - reference_id: PMID:17070044
      supporting_text: strongly inhibit liver, fat, and brain HSD1
- term:
    id: GO:0070524
    label: 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
  evidence_type: IDA
  original_reference_id: PMID:17919905
  qualifier: enables
  review:
    summary: Enzyme-inhibition and X-ray co-crystal study confirming the 11beta-HSD1 catalytic
      activity used as the assay target, consistent with the core dehydrogenase function.
    action: ACCEPT
    reason: Experimental evidence of the core enzymatic activity in an inhibitor/structure study.
    supported_by:
    - reference_id: PMID:17919905
      supporting_text: 2-anilinothiazolones were prepared as inhibitors of
- term:
    id: GO:0016020
    label: membrane
  evidence_type: HDA
  original_reference_id: PMID:19946888
  qualifier: located_in
  review:
    summary: High-throughput mass-spectrometry membrane-proteome study of an NK-like cell line
      that identified HSD11B1 among ~1843 proteins. "Membrane" is a generic parent of the
      specific and well-supported ER-membrane localization, and the annotation derives from a
      broad proteomics screen rather than targeted localization.
    action: MARK_AS_OVER_ANNOTATED
    reason: Not wrong (the enzyme is a membrane protein) but uninformatively general relative to
      the specific ER membrane localization; sourced from a high-throughput proteomics dataset.
    supported_by:
    - reference_id: PMID:19946888
      supporting_text: identified 1843 proteins with high confidence scores
core_functions:
- description: NADP(H)-dependent 11-beta-hydroxysteroid dehydrogenase / oxoreductase that
    interconverts inactive and active glucocorticoids, acting predominantly in vivo as a
    reductase converting cortisone to cortisol at the ER membrane, thereby amplifying
    pre-receptor glucocorticoid action.
  molecular_function:
    id: GO:0070524
    label: 11-beta-hydroxysteroid dehydrogenase (NADP+) activity
  directly_involved_in:
  - id: GO:0008211
    label: glucocorticoid metabolic process
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  supported_by:
  - reference_id: file:human/HSD11B1/HSD11B1-uniprot.txt
    supporting_text: Reaction=cortisone + NADPH + H(+) = cortisol + NADP(+);
  - reference_id: PMID:15513927
    supporting_text: ER-localized membrane protein that catalyzes the interconversion of cortisone
references:
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt
  findings: []
- id: GO_REF:0000116
  title: Automatic Gene Ontology annotation based on Rhea mapping
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: file:human/HSD11B1/HSD11B1-uniprot.txt
  title: UniProtKB entry P28845 (DHI1_HUMAN), 11-beta-hydroxysteroid dehydrogenase 1
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Curated UniProtKB record; source of catalytic-activity, subunit, subcellular
      location and function statements used as file-quote support.
- id: PMID:10497248
  title: The N-terminal anchor sequences of 11beta-hydroxysteroid dehydrogenases determine
    their orientation in the endoplasmic reticulum membrane.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Establishes ER-membrane localization and single-pass type II topology with
      lumen-facing catalytic domain; also reports enzymatic activity. Abstract-only in cache.
- id: PMID:15152005
  title: Appropriate function of 11beta-hydroxysteroid dehydrogenase type 1 in the
    endoplasmic reticulum lumen is dependent on its N-terminal region sharing similar
    topological determinants with 50-kDa esterase.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Supports pre-receptor glucocorticoid function, ER-lumen orientation dependence
      of activity, and 7-ketocholesterol metabolism. Abstract-only in cache.
- id: PMID:15513927
  title: Conformational flexibility in crystal structures of human 11beta-hydroxysteroid
    dehydrogenase type I provide insights into glucocorticoid interconversion and
    enzyme regulation.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Crystal structures establishing cortisone/cortisol interconversion,
      oligomerization motif, and adipose-tissue disease relevance. Abstract-only in cache.
- id: PMID:17070044
  title: Adamantane sulfone and sulfonamide 11-beta-HSD1 Inhibitors.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Inhibitor study confirming 11beta-HSD1 activity in liver, fat and brain.
      Abstract-only in cache.
- id: PMID:17919905
  title: The discovery of 2-anilinothiazolones as 11beta-HSD1 inhibitors.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Inhibitor/X-ray co-crystal study confirming enzymatic activity and structure.
      Abstract-only in cache.
- id: PMID:18069989
  title: Structural characterization and pharmacodynamic effects of an orally active
    11beta-hydroxysteroid dehydrogenase type 1 inhibitor.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Structural inhibitor study; supports homodimeric assembly. Abstract-only in cache.
- id: PMID:18485702
  title: Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid
    dehydrogenase type 1.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Structural inhibitor study; supports homodimeric assembly. Abstract-only in cache.
- id: PMID:18553955
  title: Discovery of novel, potent benzamide inhibitors of 11beta-hydroxysteroid
    dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition
    ex vivo model.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Structural inhibitor study; supports homodimeric assembly. Abstract-only in cache.
- id: PMID:19217779
  title: Discovery and optimization of piperidyl benzamide derivatives as a novel
    class of 11beta-HSD1 inhibitors.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Structural inhibitor study; supports homodimeric assembly. Abstract-only in cache.
- id: PMID:19946888
  title: Defining the membrane proteome of NK cells.
  findings: []
  reference_review:
    relevance: LOW
    correctness: VERIFIED
    review_notes: High-throughput membrane-proteome MS screen; source of the generic 'membrane'
      HDA annotation, not targeted localization evidence.
- id: Reactome:R-HSA-194023
  title: HSD11B2,HSD11B1 dimer oxidise CORT to COR
  findings: []
- id: Reactome:R-HSA-9757706
  title: HSD11B1 hydrogenates PREDN to PREDL in hepatic cell
  findings: []